HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Akio Kanatani Selected Research

imetit

1/2008Distinctive role of central histamine H3 receptor in various orexigenic pathways.
9/2006Therapeutic potential of histamine H3 receptor agonist for the treatment of obesity and diabetes mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Akio Kanatani Research Topics

Disease

17Obesity
12/2009 - 06/2002
16Body Weight (Weight, Body)
12/2009 - 06/2002
5Hyperphagia (Overeating)
01/2008 - 06/2002
2Diarrhea
04/2010 - 02/2010
2Fatty Liver
08/2008 - 01/2007
2Metabolic Syndrome (Dysmetabolic Syndrome X)
02/2006 - 01/2006
1Constipation
02/2010
1Type 2 Diabetes Mellitus (MODY)
06/2009
1Pain (Aches)
06/2009
1Insulin Resistance
07/2008
1Weight Loss (Weight Reduction)
10/2006
1Overweight
10/2006
1Diabetes Mellitus
09/2006
1Dehydration (Water Stress)
07/2006
1Non-alcoholic Fatty Liver Disease
02/2006
1Morbid Obesity
02/2006
1Cognitive Dysfunction
01/2006
1Epilepsy (Aura)
01/2006
1Disorders of Excessive Somnolence (Hypersomnia)
01/2006
1Hyperinsulinism (Hyperinsulinemia)
05/2003
1Hypercholesterolemia
05/2003

Drug/Important Bio-Agent (IBA)

7Neuropeptide YIBA
02/2010 - 06/2002
3Insulin (Novolin)FDA Link
06/2009 - 06/2006
3Histamine (Histamine Dihydrochloride)FDA Link
01/2008 - 01/2006
3thioperamideIBA
01/2008 - 07/2006
3neuropeptide Y5 receptorIBA
10/2006 - 05/2003
2melanin-concentrating hormone (melanin concentrating hormone)IBA
12/2009 - 08/2008
2Pharmaceutical PreparationsIBA
07/2009 - 01/2006
2LeptinIBA
06/2009 - 06/2006
2CholesterolIBA
06/2009 - 06/2006
2NociceptinIBA
06/2009 - 01/2008
2LigandsIBA
06/2009 - 09/2006
2imetitIBA
01/2008 - 09/2006
2Messenger RNA (mRNA)IBA
01/2007 - 11/2003
2Histamine H3 Receptors (Histamine H3 Receptor)IBA
09/2006 - 07/2006
1Dinoprostone (PGE2)FDA Link
04/2010
1neuropeptide Y2 receptorIBA
04/2010
1Castor Oil (Oil, Castor)IBA
04/2010
1ProstaglandinsIBA
04/2010
1Serotonin (5 Hydroxytryptamine)IBA
04/2010
1Pancreatic Polypeptide (Pancreatic Polypeptide (PP))IBA
02/2010
1neuropeptide Y-Y1 receptorIBA
08/2009
1SecretagoguesIBA
06/2009
1Opioid Receptors (Opioid Receptor)IBA
06/2009
1Glucagon-Like Peptide 1 (GLP 1)IBA
06/2009
1Methionine (L-Methionine)FDA Link
08/2008
1Triglycerides (Triacylglycerol)IBA
08/2008
1Choline (Choline Chloride)IBA
08/2008
1Spironolactone (Aldactone)FDA LinkGeneric
07/2008
1sibutramine (Meridia)FDA Link
07/2008
1kappa Opioid Receptors (kappa Opioid Receptor)IBA
01/2008
1(trans)-Isomer 3,4- Dichloro- N- methyl- N- (2- (1- pyrrolidinyl)- cyclohexyl)- benzeneacetamideIBA
01/2008
1Opioid Analgesics (Opioids)IBA
01/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2007
1Collagen Type I (Type I Collagen)IBA
01/2007
1trans- N- (1- (2- fluorophenyl)- 1h- pyrazol- 3- yl)- 1'- oxo- spiro(cyclohexane- 1,3'(1'H)- furo(3,4- C)pyridine)- 4- carboxamideIBA
10/2006
1Angiotensin IIIBA
07/2006
1RFamide peptideIBA
06/2006
1Leptin ReceptorsIBA
05/2006
1Tetracycline (Achromycin)FDA LinkGeneric
02/2006
1Fatty Acids (Saturated Fatty Acids)IBA
02/2006
1NeuropeptidesIBA
01/2006
1Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA
01/2006
1Anti-Obesity Agents (Antiobesity Drugs)IBA
07/2005
1DNA (Deoxyribonucleic Acid)IBA
11/2003
1Peptides (Polypeptides)IBA
03/2003
1CorticosteroneIBA
06/2002

Therapy/Procedure

7Intraventricular Infusions
06/2009 - 03/2003
5Oral Administration
09/2009 - 06/2002
2Therapeutics
01/2006 - 01/2006
1Subcutaneous Infusions
07/2009